Form 4: Quaker Chemical SVP Exercises RSUs, Receives New Grant

Christine Procopio Johnson, SVP and CTO of Quaker Chemical Corp, exercised restricted stock units, settled dividend equivalent rights, and received a new RSU grant.

Summary

• Christine Procopio Johnson, SVP and CTO of Quaker Chemical Corp (KWR), exercised 304 Restricted Stock Units (RSUs) and 2 Dividend Equivalent Rights (DERs) into common stock on March 15, 2026.
• 111 shares of common stock were surrendered by Johnson to satisfy tax withholding obligations upon partial vesting of RSUs, at a price of $118.45 per share.
• Johnson received a new grant of 1,013 time-based RSUs under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027.
• Following these transactions, Johnson beneficially owns 195 shares of common stock directly and 1,622 derivative securities (RSUs) directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard executive compensation activities and not indicative of significant operational or strategic shifts for Quaker Chemical Corp.

Positives

• The new grant of 1,013 time-based RSUs aligns management's interests with long-term shareholder value.
• The exercise of RSUs and settlement of DERs represent a realization of previously granted equity compensation.

Negatives

• 111 shares of common stock were surrendered to cover tax withholding, reducing the direct share ownership.

Future Outlook

The reporting person has future vesting events for 609 Restricted Stock Units from previous grants and 1,013 newly granted Restricted Stock Units, with the next installment for the new grant scheduled for March 15, 2027.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, reflecting executive compensation and equity ownership changes rather than broader industry trends. These transactions are standard for publicly traded companies and indicate ongoing executive participation in equity incentive plans.

Stakeholder Impact

• Shareholders: The transactions reflect ongoing alignment of executive interests with shareholder value through equity compensation.
• Employees: The RSU grants are part of the company's long-term incentive plan, which can motivate key personnel.

Next Steps

• Future vesting of the remaining 609 RSUs from previous grants.
• First annual vesting installment of the 1,013 new RSUs on March 15, 2027, with subsequent installments thereafter.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, including the exercise of restricted stock units and a new grant. Such transactions are standard and do not typically indicate a change in the company's fundamental outlook or warrant a shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as the filing provides no new information to alter the existing investment thesis.

Keywords

Quaker Chemical, KWR, Form 4, Insider Transaction, Restricted Stock Units, RSU, Dividend Equivalent Rights, Executive Compensation, Christine Procopio Johnson